Home > Qtrly Results > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]

TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
Audited
Revenues ₹2,889 Cr ₹2,859 Cr ₹2,745 Cr ₹2,732 Cr ₹2,660 Cr ₹2,591 Cr ₹2,491 Cr ₹2,491 Cr
Expenses ₹1,950 Cr ₹1,955 Cr ₹1,862 Cr ₹1,863 Cr ₹1,835 Cr ₹1,800 Cr ₹1,764 Cr ₹1,767 Cr
Operating Income ₹939 Cr ₹904 Cr ₹883 Cr ₹869 Cr ₹825 Cr ₹791 Cr ₹727 Cr ₹724 Cr
Other Income ₹-16 Cr ₹24 Cr ₹31 Cr ₹-33 Cr ₹26 Cr ₹34 Cr ₹9 Cr ₹-10 Cr
Interest ₹64 Cr ₹75 Cr ₹80 Cr ₹80 Cr ₹91 Cr ₹103 Cr ₹107 Cr ₹102 Cr
Depreciation ₹198 Cr ₹197 Cr ₹203 Cr ₹213 Cr ₹201 Cr ₹191 Cr ₹196 Cr ₹193 Cr
Profit Before Tax ₹661 Cr ₹656 Cr ₹631 Cr ₹631 Cr ₹559 Cr ₹531 Cr ₹433 Cr ₹419 Cr
Profit After Tax ₹453 Cr ₹457 Cr ₹449 Cr ₹443 Cr ₹386 Cr ₹378 Cr ₹287 Cr ₹292 Cr
EPS ₹13.38 ₹13.50 ₹13.27 ₹13.09 ₹11.40 ₹11.17 ₹8.48 ₹8.63
Industry Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS -1.8% -10.2% 51.3%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -7.1% 48%
CIPLA -3.5% -5.2% 18%
DR REDDYS LABORATORIES -3.9% -10.1% 10.1%
ZYDUS LIFESCIENCES -0.3% -7.3% 52.2%
DIVIS LABORATORIES 1.5% -2.1% 63%
MANKIND PHARMA -2.3% -3% 39.6%
LUPIN -2.4% -6.4% 73.9%
AUROBINDO PHARMA -1.5% -15.2% 27.9%

TORRENT PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

1.05 %

Y-o-Y

8.61 %

Quarters Revenues % Change
Sep2024 ₹2,889 Cr
1.05
Jun2024 ₹2,859 Cr
4.15
Mar2024 ₹2,745 Cr
0.48
Dec2023 ₹2,732 Cr
2.71
Sep2023 ₹2,660 Cr
2.66
Jun2023 ₹2,591 Cr
4.01
Mar2023 ₹2,491 Cr
0.00
Dec2022 ₹2,491 Cr -

TORRENT PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

3.87 %

Y-o-Y

13.82 %

Quarters Operating Profit % Change
Sep2024 ₹939 Cr
3.87
Jun2024 ₹904 Cr
2.38
Mar2024 ₹883 Cr
1.61
Dec2023 ₹869 Cr
5.33
Sep2023 ₹825 Cr
4.30
Jun2023 ₹791 Cr
8.80
Mar2023 ₹727 Cr
0.41
Dec2022 ₹724 Cr -
Operating Margins
Q-o-Q

2.78 %

Y-o-Y

4.77 %

Quarters Operating Margin% % Change
Sep2024 32.5%
2.78
Jun2024 31.62%
-1.71
Mar2024 32.17%
1.13
Dec2023 31.81%
2.55
Sep2023 31.02%
1.60
Jun2023 30.53%
4.59
Mar2023 29.19%
0.45
Dec2022 29.06% -

TORRENT PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-0.88 %

Y-o-Y

17.36 %

Quarters Profit After Tax % Change
Sep2024 ₹453 Cr
-0.88
Jun2024 ₹457 Cr
1.78
Mar2024 ₹449 Cr
1.35
Dec2023 ₹443 Cr
14.77
Sep2023 ₹386 Cr
2.12
Jun2023 ₹378 Cr
31.71
Mar2023 ₹287 Cr
-1.71
Dec2022 ₹292 Cr -
PAT Margins
Q-o-Q

-1.88 %

Y-o-Y

8.06 %

Quarters PAT Margin(%) % Change
Sep2024 15.68 %
-1.88
Jun2024 15.98 %
-2.32
Mar2024 16.36 %
0.86
Dec2023 16.22 %
11.78
Sep2023 14.51 %
-0.55
Jun2023 14.59 %
26.65
Mar2023 11.52 %
-1.71
Dec2022 11.72 % -

TORRENT PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-0.89 %

Y-o-Y

17.37 %

Quarters EPS % Change
Sep2024 ₹13.38
-0.89
Jun2024 ₹13.5
1.73
Mar2024 ₹13.27
1.38
Dec2023 ₹13.09
14.82
Sep2023 ₹11.4
2.06
Jun2023 ₹11.17
31.72
Mar2023 ₹8.48
-1.74
Dec2022 ₹8.63 -

You may also like the below Video Courses